Vantage Investment Advisors’s TITAN PHARMACEUTICAL INC TTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $0 | Hold |
2,273
| – | – | ﹤0.01% | 829 |
|
|
2018
Q2 | $2K | Hold |
2,273
| – | – | ﹤0.01% | 715 |
|
|
2018
Q1 | $2K | Hold |
2,273
| – | – | ﹤0.01% | 759 |
|
|
2017
Q4 | $3K | Hold |
2,273
| – | – | ﹤0.01% | 740 |
|
|
2017
Q3 | $4K | Hold |
2,273
| – | – | ﹤0.01% | 692 |
|
|
2017
Q2 | $4K | Hold |
2,273
| – | – | ﹤0.01% | 673 |
|
|
2017
Q1 | $8K | Hold |
2,273
| – | – | ﹤0.01% | 582 |
|
|
2016
Q4 | $9K | Hold |
2,273
| – | – | ﹤0.01% | 538 |
|
|
2016
Q3 | $13K | Hold |
2,273
| – | – | 0.01% | 456 |
|
|
2016
Q2 | $12K | Hold |
2,273
| – | – | 0.01% | 498 |
|
|
2016
Q1 | $11K | Buy |
+2,273
| New | +$11K | ﹤0.01% | 513 |
|
|
2015
Q3 | – | Sell |
-12,500
| Closed | -$10K | – | 849 |
|
|
2015
Q2 | $10K | Hold |
12,500
| – | – | 0.01% | 490 |
|
|
2015
Q1 | $9K | Hold |
12,500
| – | – | ﹤0.01% | 633 |
|
|
2014
Q4 | $6K | Hold |
12,500
| – | – | ﹤0.01% | 603 |
|
|
2014
Q3 | $7K | Buy |
+12,500
| New | +$7K | ﹤0.01% | 546 |
|
Vantage Investment Advisors's TTP Position: Q3 2018 in Review
Vantage Investment Advisors held its TITAN PHARMACEUTICAL INC (TTP) position steady in Q3 2018 at 2,273 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #829.
Vantage Investment Advisors first reported a position in TTP in Q3 2014 and has held it in 15 quarters since. The position peaked at $13K in Q3 2016. 1 fund tracked by Wall St. Rank holds TTP as of Q3 2018.
- Vantage Investment Advisors held 2,273 shares of TITAN PHARMACEUTICAL INC worth $0 as of Q3 2018.
- Vantage Investment Advisors left its TITAN PHARMACEUTICAL INC share count unchanged in Q3 2018.
- TITAN PHARMACEUTICAL INC made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #829 holding.
- Vantage Investment Advisors first reported a position in TITAN PHARMACEUTICAL INC in Q3 2014 and has held it in 15 quarters since.
- Vantage Investment Advisors's TITAN PHARMACEUTICAL INC position peaked at $13K in Q3 2016.
- 1 fund tracked by Wall St. Rank held TITAN PHARMACEUTICAL INC as of Q3 2018.
Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.